← Back to Patent Explorer
JPS6481A Expired / Lapsed JP ⏱️ 0.0 years remaining

H2-receptor antagonist compound

Assignee: Barisintex SA
•
Filing: 1987-12-28
•
Granted: —
•
Expires: 2007-12-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract NEW MATERIAL: Compd. expressed by formula I or its O-alkylidene, 5,6-diacyl, 6-acyl derivs. (with 2 to 16 carbon atoms) or 6-phosphate. In formula I, X is 1 to 3; Y is 1 or 2; R 1 , R 2 are each H, or R 1 is OH, and R 2 is H; Z is H, alkali (earth) metal; R 3 is a functional org. base having one or more basic groups and having H 2 -receptor antagonist characteristics, and R3 may be salt with one mol of aspartic acid, glutamic acid, caffeic acid, ferulic acid or gallic acid. EXAMPLE: N"-cyano-N'-methyl-N-2-(5-methyl-1H-imidazol-4-yl) methylthioethylguanidine [cimetidine]. USE: H 2 -receptor antagonist and drug for gastrointestinal and duodenal disorders. PROCESS: A 3-ketohexuronic acid (derivative) expressed by formula II is allowed to react with an org. base (salt) expressed by R 3 in an inert org. solvent at room temp. to the solvent refluxing temp. COPYRIGHT: (C)1989,JPO

Inventors

  • 👤 Rodes Montserrat Ballester
  • 👤 Francisco Eugenio Palomo-Nicolau
  • 👤 Oller Jose Maria Solis
  • 👤 Coll Antonio Luis Palomo

Bibliographic Details

Application Number —
Jurisdiction JP
Data Source google_patents
Last Synchronized 2026-10-23 12:52
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/54; C07D233/64; A; A61; A61P; A61P1/00; A61P1/04; A61P43/00; C07C; C07C65/00; C07C65/01; C07C65/03; C07D277/00; C07D277/02; C07D277/20; C07D277/32; C07D277/38; C07D277/44; C07D277/48; C07D285/00; C07D285/01; C07D285/02; C07D285/04; C07D285/10; C07D307/00; C07D307/02; C07D307/34; C07D307/38; C07D307/52; C07D307/56; C07D307/62; C07D405/00; C07D405/14

Claims Analysis

Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag